Literature DB >> 20625443

Latent Regression Analysis.

Thaddeus Tarpey1, Eva Petkova.   

Abstract

Finite mixture models have come to play a very prominent role in modelling data. The finite mixture model is predicated on the assumption that distinct latent groups exist in the population. The finite mixture model therefore is based on a categorical latent variable that distinguishes the different groups. Often in practice distinct sub-populations do not actually exist. For example, disease severity (e.g. depression) may vary continuously and therefore, a distinction of diseased and not-diseased may not be based on the existence of distinct sub-populations. Thus, what is needed is a generalization of the finite mixture's discrete latent predictor to a continuous latent predictor. We cast the finite mixture model as a regression model with a latent Bernoulli predictor. A latent regression model is proposed by replacing the discrete Bernoulli predictor by a continuous latent predictor with a beta distribution. Motivation for the latent regression model arises from applications where distinct latent classes do not exist, but instead individuals vary according to a continuous latent variable. The shapes of the beta density are very flexible and can approximate the discrete Bernoulli distribution. Examples and a simulation are provided to illustrate the latent regression model. In particular, the latent regression model is used to model placebo effect among drug treated subjects in a depression study.

Entities:  

Year:  2010        PMID: 20625443      PMCID: PMC2897159          DOI: 10.1177/1471082X0801000202

Source DB:  PubMed          Journal:  Stat Modelling        ISSN: 1471-082X            Impact factor:   2.039


  12 in total

1.  The placebo enigma in antidepressant clinical trials.

Authors:  A Khan; W A Brown
Journal:  J Clin Psychopharmacol       Date:  2001-04       Impact factor: 3.153

Review 2.  Treatment of depression--newer pharmacotherapies.

Authors:  C D Mulrow; J W Williams; M Trivedi; E Chiquette; C Aguilar; J E Cornell; R Badgett; P H Noel; V Lawrence; S Lee; M Luther; G Ramirez; W S Richardson; K Stamm
Journal:  Evid Rep Technol Assess (Summ)       Date:  1999-03

3.  Finite mixture modeling with mixture outcomes using the EM algorithm.

Authors:  B Muthén; K Shedden
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

4.  Allometric extension.

Authors:  S Bartoletti; B D Flury; D G Nel
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

5.  Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.

Authors:  P J McGrath; J W Stewart; E Petkova; F M Quitkin; J D Amsterdam; J Fawcett; F W Reimherr; J F Rosenbaum; C M Beasley
Journal:  J Clin Psychiatry       Date:  2000-07       Impact factor: 4.384

6.  Latent class regression on latent factors.

Authors:  Jia Guo; Melanie Wall; Yasuo Amemiya
Journal:  Biostatistics       Date:  2005-08-03       Impact factor: 5.899

7.  Clinical features of depressed patients who do and do not improve with placebo.

Authors:  W A Brown; M F Johnson; M G Chen
Journal:  Psychiatry Res       Date:  1992-03       Impact factor: 3.222

8.  Coronary risk factor screening in three rural communities. The CORIS baseline study.

Authors:  J E Rossouw; J P Du Plessis; A J Benadé; P C Jordaan; J P Kotzé; P L Jooste; J J Ferreira
Journal:  S Afr Med J       Date:  1983-09-17

Review 9.  How should efficacy be evaluated in randomized clinical trials of treatments for depression?

Authors:  M E Thase
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 10.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

View more
  6 in total

1.  Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.

Authors:  Ralitza Gueorguieva; Craig Mallinckrodt; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2011-12

2.  Predicting potential placebo effect in drug treated subjects.

Authors:  Eva Petkova; Thaddeus Tarpey; Usha Govindarajulu
Journal:  Int J Biostat       Date:  2009-07-06       Impact factor: 0.968

3.  Modelling Placebo Response via Infinite Mixtures.

Authors:  Thaddeus Tarpey; Eva Petkova
Journal:  JP J Biostat       Date:  2010-06-01

4.  LATENT CLASS MODELING USING MATRIX COVARIATES WITH APPLICATION TO IDENTIFYING EARLY PLACEBO RESPONDERS BASED ON EEG SIGNALS.

Authors:  Bei Jiang; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  Ann Appl Stat       Date:  2017-10-05       Impact factor: 2.083

5.  CLASSIFICATION OF IRANIAN NURSES ACCORDING TO THEIR MENTAL HEALTH OUTCOMES USING GHQ-12 QUESTIONNAIRE: A COMPARISON BETWEEN LATENT CLASS ANALYSIS AND K-MEANS CLUSTERING WITH TRADITIONAL SCORING METHOD.

Authors:  Jamshid Jamali; Seyyed Mohammad Taghi Ayatollahi
Journal:  Mater Sociomed       Date:  2015-10-05

6.  A New Measurement Equivalence Technique Based on Latent Class Regression as Compared with Multiple Indicators Multiple Causes.

Authors:  Jamshid Jamali; Seyyed Mohammad Taghi Ayatollahi; Peyman Jafari
Journal:  Acta Inform Med       Date:  2016-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.